Vincent Doré

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Akinori Nakamura, Naoki Kaneko, Victor L. Villemagne et al. · Nature · 2018 · 1.6K citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Biomarkers +6

Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot et al. · Nature Medicine · 2022 · 446 citations · Full text

Multisite study of the relationships between <i>antemortem</i> [¹¹C]PIB‐PET Centiloid values and <i>postmortem</i> measures of Alzheimer's disease neuropathology

Renaud La Joie, Nagehan Ayakta, William W. Seeley et al. · Alzheimer s & Dementia · 2018 · 307 citations · Full text

Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts

Rachel F. Buckley, Elizabeth C. Mormino, Rebecca E. Amariglio et al. · Alzheimer s & Dementia · 2018 · 264 citations · Full text

Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

Pratishtha Chatterjee, Steve Pedrini, James D. Doecke et al. · Alzheimer s & Dementia · 2022 · 260 citations · Full text